Business Description
Transgene Biotek Ltd
ISIN : INE773D01018
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 1.31 | |||||
Debt-to-EBITDA | -105.35 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.18 | |||||
Beneish M-Score | 0.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.3 | |||||
3-Year EBITDA Growth Rate | -20.8 | |||||
3-Year EPS without NRI Growth Rate | 59.7 | |||||
3-Year Book Growth Rate | -20.6 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.3 | |||||
9-Day RSI | 44.88 | |||||
14-Day RSI | 42.46 | |||||
12-1 Month Momentum % | 95.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.1 | |||||
Quick Ratio | 0.1 | |||||
Days Inventory | 24722.67 | |||||
Days Sales Outstanding | 16.64 | |||||
Days Payable | 152983.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | -1.61 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 99.73 | |||||
Operating Margin % | -533.93 | |||||
Net Margin % | -172.2 | |||||
FCF Margin % | 2.5 | |||||
ROE % | -2.87 | |||||
ROA % | -0.22 | |||||
ROIC % | -0.65 | |||||
ROC (Joel Greenblatt) % | -13.14 | |||||
ROCE % | -0.17 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 1556 | |||||
PS Ratio | 258.65 | |||||
PB Ratio | 4.13 | |||||
Price-to-Tangible-Book | 10.63 | |||||
Price-to-Free-Cash-Flow | 7760 | |||||
Price-to-Operating-Cash-Flow | 7760 | |||||
EV-to-EBIT | -323.08 | |||||
EV-to-EBITDA | -547.71 | |||||
EV-to-Revenue | 395.18 | |||||
EV-to-FCF | 15857.04 | |||||
Price-to-Projected-FCF | 10.21 | |||||
Earnings Yield (Greenblatt) % | -0.31 | |||||
FCF Yield % | 0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Transgene Biotek Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 1.842 | ||
EPS (TTM) (₹) | -0.05 | ||
Beta | 2.14 | ||
Volatility % | 110.28 | ||
14-Day RSI | 42.46 | ||
14-Day ATR (₹) | 0.57674 | ||
20-Day SMA (₹) | 7.836 | ||
12-1 Month Momentum % | 95.65 | ||
52-Week Range (₹) | 3.84 - 12.46 | ||
Shares Outstanding (Mil) | 75.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Transgene Biotek Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Transgene Biotek Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Transgene Biotek Ltd Frequently Asked Questions
What is Transgene Biotek Ltd(BOM:526139)'s stock price today?
When is next earnings date of Transgene Biotek Ltd(BOM:526139)?
Does Transgene Biotek Ltd(BOM:526139) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |